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Abstract 
A Saccharomyces cerevisiae fermentation product (NutriTek; Diamond V, Cedar Rapids, IA) was fed from 
29 ± 5 days before calving and through 42 days in milk (DIM) to evaluate the effects on feed intake 
parameters, milk production, and metabolism. Treatments were control (n = 30) or 18 g/d NutriTek (NT, n 
= 34) provided as total mixed rations. Cows were individually fed 3×/day prepartum and 2×/day 
postpartum. Cows were milked 2×/day with samples taken 2×/week for composition analysis. Body 
weight (BW) was measured at enrollment (day -29 ± 5), day 0, and day 42 relative to calving, and body 
condition was scored weekly. Blood samples were collected during weeks -4, -2, 1, 2, and 5 relative to 
calving for biomarkers of metabolism and inflammation. To evaluate adaptive immunity, cows were 
challenged with a subcutaneous injection of ovalbumin (egg protein) and immune response was 
determined by serum concentrations of anti-ovalbumin immunoglobulin G (IgG) on days 7, 21, 28, and 35 
of lactation. Overall dry matter intake, BW, body condition score, and milk yield were not different between 
treatments. NutriTek did alter feeding behavior by increasing the number of meals consumed with less 
time between those meals. Milk fat concentration increased with NT during weeks 4 and 5 of lactation, 
which contributed to an increase in fat yield during those weeks. There were tendencies for greater milk 
lactose yield in control cows and greater milk urea nitrogen concentration in NT, but no treatment 
differences for milk protein concentration or somatic cell count. Assuming equal digestibility, energy 
balance was more negative for NT during weeks 4 and 5, mirroring the increase in milk fat during that 
time. Energy density of diets calculated from observed ECM yield and BW change did not differ by 
treatment. Plasma concentrations of free fatty acids, β-hydroxybutyrate (BHB), glucose, insulin, and the 
inflammation marker haptoglobin did not differ between treatments. NutriTek increased the incidence of 
subclinical ketosis (12 vs. 38%, diagnosed by urine ketones). There was no overall treatment effect for 
immune response to vaccination; however, a treatment × parity interaction indicated greater antibody 
concentration in primiparous cows supplemented with NT. A partial budget analysis accounting for milk 
income, feed cost, and expense associated with ketosis treatment indicated an additional $0.35 daily 
profit per cow for NT vs. control. In conclusion, NT supplementation during the transition period altered 
feeding behavior and milk fat concentration and ultimately appeared profitable in this scenario, despite 
the increased incidence of subclinical ketosis and a lack of response in early lactation milk yield. 
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Summary
A Saccharomyces cerevisiae fermentation product (NutriTek; Diamond V, Cedar 
Rapids, IA) was fed from 29 ± 5 days before calving and through 42 days in milk (DIM) 
to evaluate the effects on feed intake parameters, milk production, and metabolism. 
Treatments were control (n = 30) or 18 g/d NutriTek (NT, n = 34) provided as total 
mixed rations. Cows were individually fed 3×/day prepartum and 2×/day postpartum. 
Cows were milked 2×/day with samples taken 2×/week for composition analysis. Body 
weight (BW) was measured at enrollment (day -29 ± 5), day 0, and day 42 relative to 
calving, and body condition was scored weekly. Blood samples were collected during 
weeks -4, -2, 1, 2, and 5 relative to calving for biomarkers of metabolism and inflam-
mation. To evaluate adaptive immunity, cows were challenged with a subcutaneous 
injection of ovalbumin (egg protein) and immune response was determined by serum 
concentrations of anti-ovalbumin immunoglobulin G (IgG) on days 7, 21, 28, and 35 
of lactation. Overall dry matter intake, BW, body condition score, and milk yield were 
not different between treatments. NutriTek did alter feeding behavior by increasing the 
number of meals consumed with less time between those meals. Milk fat concentration 
increased with NT during weeks 4 and 5 of lactation, which contributed to an increase 
in fat yield during those weeks. There were tendencies for greater milk lactose yield in 
control cows and greater milk urea nitrogen concentration in NT, but no treatment 
differences for milk protein concentration or somatic cell count. Assuming equal digest-
ibility, energy balance was more negative for NT during weeks 4 and 5, mirroring the 
increase in milk fat during that time. Energy density of diets calculated from observed 
ECM yield and BW change did not differ by treatment. Plasma concentrations of free 
fatty acids, β-hydroxybutyrate (BHB), glucose, insulin, and the inflammation marker 
haptoglobin did not differ between treatments. NutriTek increased the incidence of 
subclinical ketosis (12 vs. 38%, diagnosed by urine ketones). There was no overall treat-
ment effect for immune response to vaccination; however, a treatment × parity interac-
tion indicated greater antibody concentration in primiparous cows supplemented with 
NT. A partial budget analysis accounting for milk income, feed cost, and expense associ-
1Diamond V, Cedar Rapids, IA.
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ated with ketosis treatment indicated an additional $0.35 daily profit per cow for NT 
vs. control. In conclusion, NT supplementation during the transition period altered 
feeding behavior and milk fat concentration and ultimately appeared profitable in this 
scenario, despite the increased incidence of subclinical ketosis and a lack of response in 
early lactation milk yield.
Introduction 
Saccharomyces cerevisiae fermentation products have been reported to influence the 
rumen environment, increasing fiber digestion, lactic acid utilization, and rumen 
pH. These attributes may be particularly advantageous during periods of stress, and 
may explain why dietary Saccharomyces cerevisiae fermentation product increases dry 
matter intake in early lactation by an average of 1.37 lb/day and energy-corrected milk 
by 3.64 lb/day. Beyond these proposed effects of Saccharomyces cerevisiae fermenta-
tion products on ruminal health, they may also affect transition cows through altered 
feeding behavior and immune function. 
The objective of this study was to determine the effects of a new Saccharomyces cerevi-
siae fermentation product (NutriTek, Diamond V, Cedar Rapids, IA) on feed intake, 
feeding behavior, milk production and composition, energy balance, metabolism, and 
adaptive immunity during the transition period in dairy cows. 
Experimental Procedures
Sixty-four prepartum Holstein cows (50 multiparous, 14 primiparous) were used in 
a randomized block design. Cows were blocked by parity, expected calving date, and 
previous 305ME yield, then randomly assigned to treatment within block. Treatments 
were either control (n = 30) or 18 grams NT per day (n = 34) that was incorporated 
into a total mixed ration (TMR). Treatments were fed from -29 ± 5 to 42 days rela-
tive to calving. Feed ingredient samples were collected once weekly, composited by 
4 months, and analyzed by wet chemistry methods for dry matter, neutral detergent 
fiber, starch, crude protein, ether extract, and ash content (Dairy One, Ithaca, NY). 
Chemical analyses of individual feed ingredients were used for determination of TMR 
nutrient composition (Table 1).
Prepartum cows were fed treatment diets using an electronically gated feeding system 
(Roughage Intake System; Insentec B.V., Marknesse, the Netherlands). All cows on 
a given treatment diet were allowed access to 4 feed bins assigned to that treatment, 
and no more than 6 animals shared those 4 bins at any given time. To account for 
the capacity of the feed bins and potential bunk favoritism, prepartum cows were 
fed 3×/day. Upon calving, cows were moved to a tie-stall facility where they were fed 
individually twice daily. Both feeding systems electronically recorded individual feed 
consumption and meal patterns. As-fed feed intake was recorded on a daily basis and 
adjusted by TMR dry matter for determination of meal and daily dry matter intake 
(DMI). For feeding behavior analysis, the inter-meal interval (IMI) was defined by a gap 
of at least 12 minutes between distinct meals and the minimum meal weight was 0.9 lb. 
Cows were milked 2×/day with milk weights recorded for each milking. Milk samples 
were collected 2×/week and analyzed for concentrations of fat, true protein, lactose 
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(B-2000 Infrared Analyzer; Bentley Instruments, Chaska, MN), milk urea nitrogen 
(MUN; MUN spectrophotometer, Bentley Instruments), and somatic cells (SCC 500, 
Bentley Instruments) by MQT Laboratories (Kansas City, MO). Energy-corrected milk 
was calculated as (0.327 × milk yield) + (12.95 × fat yield) + (7.65 × protein yield), and 
fat-corrected milk (FCM) was calculated as (0.432 × milk yield) + (16.216 × fat yield).
Body condition score (BCS) was recorded weekly by 3 trained investigators. Body 
weight was measured at enrollment (-29 ± 5 days relative to calving), after calving, 
and at 42 DIM. Prepartum energy balance was calculated as net energy (NE) intake – 
(NE maintenance + NE pregnancy). A total of 5 jugular blood samples were taken from 
each cow on the following weeks relative to calving: -4, -2, 1, 2, and 5. Bloods samples 
were analyzed for concentrations of free fatty acids, β-hydroxybutyrate, glucose, insulin, 
and haptoglobin. To evaluate adaptive immunity, cows were challenged with a subcu-
taneous injection of ovalbumin and Quil-A adjuvant on days 7 and 21 postpartum. 
Immune response was measured by anti-ovalbumin IgG concentration in serum 
samples collected on days 7, 21, 28, and 35 postpartum.
Cow health was evaluated daily by visual inspection, rectal temperature, and urine 
acetoacetic acid concentration (KetoCare, TRUEplus). Cows were monitored for 
disorders including ketosis (urine acetoacetic acid concentration > 40 mg/dL), milk 
fever, displaced abomasum, retained placenta, metritis, and mastitis. All diagnosed 
disease and health issues were recorded.
Results and Discussion 
Dry Matter Intake and Feeding Behavior 
Dry matter intake exhibited the typical decrease as calving approached and increased 
with the progression of lactation (Figure 1A); however, DMI was not altered by NT 
supplementation (P > 0.69). Similar to DMI, all feeding behavior parameters except 
IMI (P = 0.28) were influenced by day relative to calving (P < 0.01; Table 2). NutriTek 
tended to increase prepartum meal count (P = 0.06; Figure 1B) and decreased the 
time between meals (P = 0.03; Figure 1C), specifically during the 10 days preceding 
calving. A treatment × week interaction for meal weight (P = 0.03) indicated control 
cows consumed larger meals during days -7 to -4 relative to calving. These data suggest 
that NT cows consumed lighter meals more often with less time between those meals 
leading up to calving. Interestingly, the treatment × parity interaction for meal count 
and IMI (P ≤ 0.03) suggested this altered feeding behavior with NT mainly applied 
to primiparous cows. Meal count was greater (9.7 vs. 8.5 ± 0.4 meals/day) and IMI 
lesser (0.65 vs. 0.82 ± 0.04 hours) for primiparous NT cows, but both were similar for 
multiparous NT and control cows (8.8 vs. 8.9 ± 0.2 meals/day and 0.82 vs. 0.81 ± 0.02 
hours). Postpartum, NT cows continued to consume more meals (P = 0.03) with a 
tendency for less time between meals (P = 0.07). Considering the lesser proportion of 
primiparous cows in this study, the prepartum treatment × parity interaction for meal 
count could partially explain why we observed differences in feeding behavior that did 
not translate into greater DMI. There was no treatment × parity interaction (P > 0.20) 
for postpartum meal count, therefore this potential explanation would not extend after 
calving. 
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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These modulations to feeding behavior have been documented in previous transition 
cow studies supplementing Saccharomyces cerevisiae fermentation product. The more 
consistent meal patterns may contribute to improved, more stable rumen function in 
NT-fed cows.
Body Weight, Body Condition, Milk Production, and Energy Balance
Cows experienced the typical decrease in body condition and body weight during the 
transition to lactation (P < 0.001); however, there was no effect of treatment or treat-
ment × time interaction for either (P > 0.50). On average, cows lost 0.7 BCS units 
(3.6 to 2.9) and 196 lb of BW (1,519 to 1,323 lb) during the experiment.  
As shown in Table 3 and Figure 2A, most milk production parameters (milk yield, 
energy-corrected milk, and fat-corrected milk) were not affected by treatment 
(P ≥ 0.32). Milk fat concentration increased (P = 0.01) and milk fat yield tended to 
be greater (P = 0.10; Figure 2B) for NT cows, with differences in weeks 4 and 5. We 
observed no differences for milk protein yield and content, lactose yield, and milk 
somatic cell linear score (P > 0.15). Milk lactose concentration tended to be greater for 
control (P = 0.06) and MUN tended to be greater for NT (P = 0.06). Greater milk fat 
content in transition cow studies could indicate greater release of body fat; however, 
lack of difference in BCS and timing of the milk fat response (week 4 and 5) make 
that unlikely. Risk of ruminal acidosis is increased during the postpartum period. It is 
possible the more consistent meal patterns contributed to improved rumen function, 
which could decrease the risk for shifts in biohydrogenation pathways and milk fat 
depression. Saccharomyces cerevisiae fermentation product has also been documented 
to increase fiber-digesting bacterial populations that largely produce acetate, one of the 
main lipogenic precursors for de novo fatty acid synthesis. However, these potential 
mechanisms are unlikely to be involved only during weeks 4 and 5, making it a less 
compelling explanation. The exact mechanisms involved in the observed increase in 
milk fat yield are unclear. 
Energy balance (calculated assuming equal nutrient digestibility across diets) differed 
by week (P < 0.001) and treatment (P = 0.03). The lesser energy balance for NT during 
weeks 4 and 5 aligns with the time of increased milk fat concentration. Energy balance 
was also less in primiparous compared to multiparous cows (-7.02 vs. -3.47 ± 0.83 
Mcal/day; P < 0.01). To account for possible differences in nutrient digestibility, we 
calculated energy density of the diet as energy required (milk energy + maintenance) 
minus energy supplied from mobilized body reserves, divided by dry matter intake. This 
calculation of observed feed energy (observed diet NEL concentration) could provide 
some insight into changes in digestible or metabolizable energy supply from the diet; 
however, no difference between diets was detected (P = 0.18). 
Metabolic Signaling and Adaptive Immune Response
Changes over time for plasma free fatty acids, BHB, insulin, and glucose reflected the 
typical metabolic and endocrine changes during the transition period (P < 0.001). 
The metabolic profile was not altered by NT supplementation (P > 0.35; Table 4). 
Plasma haptoglobin concentration, a marker of inflammation, tended to differ by week 
(P = 0.08), but not by treatment (P = 0.18).
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Potential effects of NT on the adaptive immune system were evaluated by the response 
to a subcutaneous injection of ovalbumin. Antibody production increased after the 
challenge (P < 0.001) as expected. There was no overall treatment effect (P = 0.25), but 
the treatment × parity interaction indicated greater anti-ovalbumin IgG concentration 
in primiparous cows supplemented with NT compared to control (0.36 vs. 0.28 ± 0.08 
optical density; P = 0.08). It is possible that NT enhanced B lymphocyte activation, 
thus increasing antibody production in primiparous cows. 
Disease Incidence
Incidences of common periparturient diseases occurring throughout the study period 
are outlined in Table 5. No metabolic diseases - except ketosis - differed by treat-
ment (P > 0.10). Incidence of subclinical ketosis (SCK) diagnosed via urine ketones 
was greater in cows supplemented with NT compared to control cows (38% vs. 12%; 
P = 0.02; Figure 4A) and days of glucogenic treatment were also greater (1.7 vs. 0.4 ± 
0.3 d; P = 0.01). To understand the observed increase in SCK incidence, despite little 
evidence of an overall treatment effect on plasma ketone concentrations or decreased 
energy balance during the window of time when ketosis was observed, a deeper inves-
tigation was carried out. The majority of ketosis diagnosis occurred between 10 and 
20 days in milk (n = 8, NT = 6, control = 2). Because of this timing, we used week 2 
plasma data to explore potential mechanisms underlying this effect. First, urine diag-
nosis of ketosis by urine ketones was effective, as plasma BHB concentrations were 
clearly greater in cows diagnosed with SCK versus those that were not (P < 0.001). 
Analysis of week 2 BHB concentrations demonstrated a parity × treatment interaction 
(P = 0.02; Figure 4B): treatment did not impact BHB in primiparous cows, but NT 
increased BHB concentrations in multiparous cows. The observed increase in BHB in 
multiparous cows fed NT occurred without any other signs of poor health – we did not 
observe any clinical signs, and feed intake was not impaired in this group. We suspect 
that the increased BHB production is a metabolic response to NT rather than a true 
sign of disease.
Partial Budget
A simple partial budget analysis was conducted incorporating milk income, feed costs, 
and the expense associated with treating ketosis (Table 6). Milk income was generated 
using milk fat and protein prices of $2.51 and $1.78 per lb, respectively. Individual feed 
ingredient costs represented those of August 2016. Prepartum and postpartum DMI 
and diet composition were used to calculate diet prices on a daily cow basis, and the 
cost of NT was incorporated at $0.13 per cow daily. Ketosis cases were treated with 
propylene glycol ($4/treatment) for 3 days, so ketosis incidence and treatment costs 
were then used to determine the ketosis expense on a daily per-cow basis for the 42-day 
postpartum period. This analysis revealed an additional $0.35 profit per cow daily with 
NT supplementation. This analysis included all numerical differences between treat-
ments; however, since DMI and production parameters other than milk fat concentra-
tion did not statistically differ between treatments, cautious interpretation is warranted.
Conclusions 
Supplementation with NT during the transition period altered prepartum and post-
partum feeding behavior, with increased meals per day and decreased time between 
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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those meals. Although no effects were detected for DMI, milk yield, milk protein, or 
SCC, milk fat percent was increased by approximately 13% in cows receiving NT, 
with differences beginning after the time period in which lipid mobilization is greatest 
during the transition period. Body weight, BCS, energy metabolites, and an inflam-
matory biomarker were unaffected. Incidence of SCK was increased with NT, but the 
mechanism through which this occurred has yet to be elucidated. Despite the increased 
incidence of SCK and no observed effect in milk yield, the increased milk fat contrib-
uted to an increased marginal economic return for NT over the first 42 days of lacta-
tion. 
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 1. Ingredient and nutritional composition of the prepartum and postpartum diets 
of control cows and cows supplemented with a Saccharomyces cerevisiae fermentation 
product (NutriTek; NT) from -29 ± 5 days relative to calving through 42 DIM
Prepartum Postpartum
Control NT Control NT
Ingredient, % of dry matter
Alfalfa hay1 --- 9.75
Alfalfa hay2 --- 9.70
Grass hay 38.03 1.62
Corn silage 19.83 22.32
Wet corn gluten feed3 18.44 23.76
Cotton seed --- 4.05
Ground corn 8.28 8.23 17.92 17.87
Micronutrient premixes 15.43 15.48 10.88 10.94
Nutrient, % of dry matter (unless otherwise specified)
Dry matter, % as-fed 63.3 59.7
Crude protein 12.9 17.0
Acid detergent fiber 25.0 17.8
Neutral detergent fiber 43.1 31.3
Nonfiber carbohydrates 30.1 37.6
Starch 15.3 22.6
Crude fat 5.1 6.3
NEL, Mcal/kg 1.42 1.66
1Lower quality alfalfa with 22.1% crude protein.
2Higher quality alfalfa with 23.9% crude protein.
3Sweet Bran (Cargill Inc., Blair, NE).
NEL = net energy for lactation.
Kansas State University Agricultural Experiment Station and Cooperative Extension Service
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Table 2. Dry matter intake (DMI), water intake, and feeding behavior parameters for control cows and cows 
supplemented with a Saccharomyces cerevisiae fermentation product (NutriTek; NT) from -29 ± 5 days relative to 
calving through 42 days in milk
P-values






DMI, lb/day 25.40 25.84 1.10 0.70 < 0.001 0.76 < 0.01 NS
Meal count/day 8.66 9.27 0.22 0.06 < 0.001 0.44 0.52 0.03
Meal weight, lb 2.89 2.84 0.13 0.75 < 0.001 0.03 < 0.01 NS
Meal length, minutes 28.28 29.49 0.94 0.28 < 0.001 0.03 0.91 NS
Inter-meal interval, hours 2.26 2.09 0.05 0.03 0.28 0.10 0.04 0.01
Postpartum measure 
Water intake, L/day 104.3 109.7 3.7 0.16 < 0.001 0.60 < 0.001 0.32
DMI, lb/day 45.38 45.62 1.15 0.84 < 0.001 0.75 < 0.001 NS
Meal count/day 11.35 12.60 0.45 0.03 < 0.001 0.70 0.52 NS
Meal weight, lb 4.39 4.45 0.24 0.83 < 0.001 0.34 0.45 NS
Meal length, minutes 23.77 25.77 1.30 0.22 < 0.001 0.62 0.05 NS
Inter-meal interval, hours 1.81 1.62 0.09 0.07 < 0.001 0.55 0.07 NS
1Pooled standard error of the mean.
2Time is by week for DMI and by day relative to calving for feeding behavior parameters.
Table 3. Lactation performance and energy balance for control cows and cows supplemented with a Saccharomyces 
cerevisiae fermentation product (NutriTek; NT) from 29 ± 5 days prepartum to 42 days in milk
P-values
Control NT SEM1 Treatment Week
Treatment 
× week
Milk, lb/day 91.18 88.71 2.78 0.43 < 0.001 0.24
Milk fat, % 3.96 4.32 0.11 0.01 < 0.001 < 0.05
Milk fat, lb/day 3.62 3.90 0.18 0.10 < 0.001 0.09
Milk protein, % 3.03 3.12 0.04 0.16 < 0.001 < 0.01
Milk protein, lb/day 2.73 2.67 0.09 0.48 < 0.001 0.61
Milk lactose, % 4.93 4.87 0.02 0.06 < 0.001 0.70
Milk lactose, lb/day 4.50 4.34 0.13 0.29 < 0.001 0.41
Milk urea nitrogen, mg/dL 11.51 12.42 0.38 0.06 < 0.001 0.21
Milk somatic cell linear score2 2.32 1.94 0.28 0.29 < 0.001 0.55
Energy-corrected milk, lb/day 96.78 99.69 3.66 0.41 < 0.001 0.09
Fat-corrected milk, lb/day 96.80 101.28 4.19 0.32 < 0.001 0.20
Energy balance, Mcal/day -4.34 -6.15 0.74 0.03 < 0.001 0.20
Observed diet NEL, Mcal/kg DM 1.83 1.90 0.04 0.18 < 0.001 0.19
1Pooled standard error of the mean.
2SCLS = log2(somatic cell count/100) + 3.
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Table 4. Metabolic and inflammatory biomarkers in plasma of control cows and cows supple-
mented with a Saccharomyces cerevisiae fermentation product (NutriTek; NT) from 29 ± 5 days 
prepartum to 42 days in milk
P-values
Control NT SEM1 Treatment Week
Treatment 
× week
Glucose, mg/dL 64.0 62.7 2.06 0.60 < 0.001 0.14
Insulin, µg/L 0.12 0.12 0.01 0.46 < 0.001 1.00
NEFA,2 μEq/L 420 444 21 0.36 < 0.001 0.13
BHBA,3 μM 556 572 22 0.57 < 0.001 0.12
Haptoglobin, ng/mL 514 575 42 0.18 0.08 0.51
1Pooled standard error of the mean.
2Non-esterified fatty acids.
3Beta-hydroxybutyric acid.
Table 5. Disease incidence for control cows and cows supplemented with Saccharomyces 





Displaced abomasum 0 2




1Includes all cows that surpassed the exclusion criteria at calving. Cows excluded from analysis due to peripartu-
rient issues were included. 
2Other includes 1 case of peritonitis resulting in death (control), 3 foot injuries (2 control, 1 NT), and 1 diarrhea/
digestive upset at calving (control).
*Fisher’s exact test: P = 0.02. No other conditions were significantly affected by treatment.
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Table 6. Partial budget analysis of supplementing cows with a Saccharomyces cerevisiae 
fermentation product (NutriTek: NT) from 28 days before calving through 42 days in 
milk
Revenue or expense category Control NT
Milk income
Fat income per cow, $2.51/lb $9.08 $9.80
Protein income per cow, $1.78/lb $4.87 $4.75
$13.94 $14.55
Feed cost1
Prepartum per cow/day $2.67 $2.85
Postpartum per cow/day $5.45 $5.61
($5.70) (5.87)
Expense due to ketosis (per cow daily over 42 days at risk)
Ketosis incidence, % 12 38
Cost of treatment per case,2 $ $12.00 $12.00
($0.03) ($0.11)
Income over feed and treatment costs $8.22 $8.57
1Overall feed cost divides prepartum feeds costs over 305 days plus postpartum feed costs.
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Figure 1. Dry matter intake (A), meal count (B), and inter-meal interval (IMI; C) for 
control cows and cows supplemented with Saccharomyces cerevisiae fermentation product 
(NutriTek, NT) from -29 ± 5 days relative to calving (DRTC) through 42 days in milk. 
An effect of time was present both prepartum and postpartum for all measures (P < 
0.001). Treatment differences are indicated by *(P < 0.05) and †(0.05 ≤ P < 0.10). A) DMI 
was not affected by NT (P ≥ 0.75). B) NT cows tended to consume more meals per day 
prepartum (P = 0.06) and did increase meals per day postpartum (P = 0.03). Prepartum 
standard error of the means = 0.22, postpartum standard error of the means = 0.45. C) 
NT decreased time between meals prepartum (P = 0.03) and tended to decrease inter-meal 
interval postpartum (P = 0.07). Prepartum standard error of the means = 0.05, post-
partum standard error of the means = 0.09.
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Figure 2. Milk yield, milk fat yield, and fat-corrected milk (FCM) of control cows and 
cows supplemented with Saccharomyces cerevisiae fermentation product (NutriTek, NT) 
from day -29 ± 5 relative to calving through 42 DIM. A) Milk yield did not differ between 
treatments (P = 0.43). There was an effect of week (P < 0.001), but no treatment × week 
interaction (P = 0.24). B) Weekly milk fat yield was not different for cows supplemented 
with NT compared to control cows (P = 0.10). Milk fat yield differed by week (P < 0.001), 
and there was a tendency for a treatment × week interaction (P = 0.09). Treatment differ-
ences are indicated by *(P < 0.05) and †(0.05 ≤ P < 0.10). C) Fat-corrected milk did not 
differ between treatments (P = 0.32) and there was no treatment × week interaction (P = 
0.20).










































Figure 3. Serum concentrations of anti-ovalbumin-IgG in cows supplemented with 
Saccharomyces cerevisiae fermentation product (NutriTek, NT) from day -29 ± 5 rela-
tive to calving through 42 days in milk and challenged with a subcutaneous injection of 
ovalbumin on day 7 of lactation. A) Anti-ovalbumin IgG concentration increased with 
time after injection (P < 0.001); however, did not differ by treatment (P = 0.25). B) The 
tendency for a treatment × parity interaction (P = 0.08) indicated greater anti-ovalbumin 
IgG concentration in primiparous NT cows compared to control. 









































Figure 4. A) Supplementation with a Saccharomyces cerevisiae fermentation product 
(NT) from day -29 ± 5 relative to calving through 42 days in milk increased incidence of 
subclinical ketosis. B) When analyzed independently, week 2 β-hydroxybutyrate (BHB) 
concentrations demonstrated a significant parity × treatment interaction with differences 
for multiparous but not primiparous cows. 
